News Focus
News Focus
icon url

Lacey1

07/04/25 8:07 PM

#493142 RE: Robot14 #493139

Any buyout should be north of 70 billion. Eli Lilly could do it easily. We are not in a hurry. The EMA is working. With approval we start trials in Rhett, Parkinsons, dementia, fragil x, and more. Revenue stream in five years with prophylactic use?